| 0065-9307 | These highlights do not include all the information needed to use INVELTYS® safely and effectively. See full prescribing information for INVELTYS. INVELTYS (loteprednol etabonate ophthalmic suspension) 1%, for topical ophthalmic use Initial U.S. Approval 1998 | Alcon Laboratories, Inc. | Alcon Research LLC | Industriale Chimica SRL |
| 0065-9307-04 | These highlights do not include all the information needed to use INVELTYS® safely and effectively. See full prescribing information for INVELTYS. INVELTYS (loteprednol etabonate ophthalmic suspension) 1%, for topical ophthalmic use Initial U.S. Approval 1998 | Alcon Laboratories, Inc. | Alcon Research LLC | Industriale Chimica SRL |
| 0065-9307-05 | These highlights do not include all the information needed to use INVELTYS® safely and effectively. See full prescribing information for INVELTYS. INVELTYS (loteprednol etabonate ophthalmic suspension) 1%, for topical ophthalmic use Initial U.S. Approval 1998 | Alcon Laboratories, Inc. | Alcon Research LLC | Industriale Chimica SRL |
| 0574-4080 | Loteprednol Etabonate Ophthalmic Suspension 0.2% | Padagis US LLC |
| 0574-4080-05 | Loteprednol Etabonate Ophthalmic Suspension 0.2% | Padagis US LLC |
| 0574-4080-10 | Loteprednol Etabonate Ophthalmic Suspension 0.2% | Padagis US LLC |
| 0574-4135 | Loteprednol Etabonate Ophthalmic Suspension, 0.5% | Padagis US LLC |
| 0574-4135-05 | Loteprednol Etabonate Ophthalmic Suspension, 0.5% | Padagis US LLC |
| 0574-4135-10 | Loteprednol Etabonate Ophthalmic Suspension, 0.5% | Padagis US LLC |
| 0574-4135-15 | Loteprednol Etabonate Ophthalmic Suspension, 0.5% | Padagis US LLC |
| 16590-007 | ALREX loteprednol etabonate ophthalmic suspension, 0.2% | STAT Rx USA LLC | PSS World Medical Inc. |
| 16590-007-05 | ALREX loteprednol etabonate ophthalmic suspension, 0.2% | STAT Rx USA LLC | PSS World Medical Inc. |
| 24208-299 | LOTEMAX® loteprednol etabonate ophthalmic suspension, 0.5% | Physicians Total Care, Inc. |
| 24208-299 | Lotemax ® loteprednol etabonate ophthalmic suspension 0.5% STERILE OPHTHALMIC SUSPENSION Rx only | Bausch & Lomb Incorporated |
| 24208-299-01 | Lotemax ® loteprednol etabonate ophthalmic suspension 0.5% STERILE OPHTHALMIC SUSPENSION Rx only | Bausch & Lomb Incorporated |
| 24208-299-05 | Lotemax ® loteprednol etabonate ophthalmic suspension 0.5% STERILE OPHTHALMIC SUSPENSION Rx only | Bausch & Lomb Incorporated |
| 24208-299-10 | Lotemax ® loteprednol etabonate ophthalmic suspension 0.5% STERILE OPHTHALMIC SUSPENSION Rx only | Bausch & Lomb Incorporated |
| 24208-299-15 | Lotemax ® loteprednol etabonate ophthalmic suspension 0.5% STERILE OPHTHALMIC SUSPENSION Rx only | Bausch & Lomb Incorporated |
| 24208-353 | ALREX loteprednol etabonate ophthalmic suspension, 0.2% | Physicians Total Care, Inc. |
| 24208-353 | Alrex ® (loteprednol etabonate ophthalmic suspension, 0.2%) STERILE OPHTHALMIC SUSPENSION | Bausch & Lomb Incorporated |
| 24208-353 | ALREX loteprednol etabonate ophthalmic suspension, 0.2% | STAT Rx USA LLC | PSS World Medical Inc. |
| 24208-353-01 | Alrex ® (loteprednol etabonate ophthalmic suspension, 0.2%) STERILE OPHTHALMIC SUSPENSION | Bausch & Lomb Incorporated |
| 24208-353-05 | Alrex ® (loteprednol etabonate ophthalmic suspension, 0.2%) STERILE OPHTHALMIC SUSPENSION | Bausch & Lomb Incorporated |
| 24208-353-10 | Alrex ® (loteprednol etabonate ophthalmic suspension, 0.2%) STERILE OPHTHALMIC SUSPENSION | Bausch & Lomb Incorporated |
| 24208-358 | These highlights do not include all the information needed to use ZYLET safely and effectively. See full prescribing information for ZYLET. ZYLET ® (loteprednol etabonate and tobramycin ophthalmic suspension) 0.5%/0.3%, for topical ophthalmic use Initial U.S. Approval: 2004 | Bausch & Lomb Incorporated | Bausch & Lomb Incoporated |
| 24208-358-01 | These highlights do not include all the information needed to use ZYLET safely and effectively. See full prescribing information for ZYLET. ZYLET ® (loteprednol etabonate and tobramycin ophthalmic suspension) 0.5%/0.3%, for topical ophthalmic use Initial U.S. Approval: 2004 | Bausch & Lomb Incorporated | Bausch & Lomb Incoporated |
| 24208-358-05 | These highlights do not include all the information needed to use ZYLET safely and effectively. See full prescribing information for ZYLET. ZYLET ® (loteprednol etabonate and tobramycin ophthalmic suspension) 0.5%/0.3%, for topical ophthalmic use Initial U.S. Approval: 2004 | Bausch & Lomb Incorporated | Bausch & Lomb Incoporated |
| 24208-358-10 | These highlights do not include all the information needed to use ZYLET safely and effectively. See full prescribing information for ZYLET. ZYLET ® (loteprednol etabonate and tobramycin ophthalmic suspension) 0.5%/0.3%, for topical ophthalmic use Initial U.S. Approval: 2004 | Bausch & Lomb Incorporated | Bausch & Lomb Incoporated |
| 24208-443 | These highlights do not include all the information needed to use LOTEMAX ointment safely and effectively. See full prescribing information for LOTEMAX ointment. LOTEMAX ® (loteprednol etabonate ophthalmic ointment) 0.5%, for topical ophthalmic use Initial U.S. Approval: 1998 | Bausch & Lomb Incorporated |
| 24208-443-01 | These highlights do not include all the information needed to use LOTEMAX ointment safely and effectively. See full prescribing information for LOTEMAX ointment. LOTEMAX ® (loteprednol etabonate ophthalmic ointment) 0.5%, for topical ophthalmic use Initial U.S. Approval: 1998 | Bausch & Lomb Incorporated |
| 24208-443-35 | These highlights do not include all the information needed to use LOTEMAX ointment safely and effectively. See full prescribing information for LOTEMAX ointment. LOTEMAX ® (loteprednol etabonate ophthalmic ointment) 0.5%, for topical ophthalmic use Initial U.S. Approval: 1998 | Bausch & Lomb Incorporated |
| 24208-503 | These highlights do not include all the information needed to use LOTEMAX safely and effectively. See full prescribing information for LOTEMAX. LOTEMAX ® (loteprednol etabonate ophthalmic gel), for topical ophthalmic use Initial U.S. Approval: 1998 | Bausch & Lomb Incorporated |
| 24208-503-07 | These highlights do not include all the information needed to use LOTEMAX safely and effectively. See full prescribing information for LOTEMAX. LOTEMAX ® (loteprednol etabonate ophthalmic gel), for topical ophthalmic use Initial U.S. Approval: 1998 | Bausch & Lomb Incorporated |
| 24208-503-48 | These highlights do not include all the information needed to use LOTEMAX safely and effectively. See full prescribing information for LOTEMAX. LOTEMAX ® (loteprednol etabonate ophthalmic gel), for topical ophthalmic use Initial U.S. Approval: 1998 | Bausch & Lomb Incorporated |
| 24208-503-96 | These highlights do not include all the information needed to use LOTEMAX safely and effectively. See full prescribing information for LOTEMAX. LOTEMAX ® (loteprednol etabonate ophthalmic gel), for topical ophthalmic use Initial U.S. Approval: 1998 | Bausch & Lomb Incorporated |
| 24208-507 | These highlights do not include all the information needed to use LOTEMAX ® SM safely and effectively. See full prescribing information for LOTEMAX ® SM. LOTEMAX ® SM (loteprednol etabonate ophthalmic gel), for topical ophthalmic use Initial U.S. Approval: 1998 | Bausch & Lomb Incorporated |
| 24208-507-01 | These highlights do not include all the information needed to use LOTEMAX ® SM safely and effectively. See full prescribing information for LOTEMAX ® SM. LOTEMAX ® SM (loteprednol etabonate ophthalmic gel), for topical ophthalmic use Initial U.S. Approval: 1998 | Bausch & Lomb Incorporated |
| 24208-507-02 | These highlights do not include all the information needed to use LOTEMAX ® SM safely and effectively. See full prescribing information for LOTEMAX ® SM. LOTEMAX ® SM (loteprednol etabonate ophthalmic gel), for topical ophthalmic use Initial U.S. Approval: 1998 | Bausch & Lomb Incorporated |
| 24208-507-07 | These highlights do not include all the information needed to use LOTEMAX ® SM safely and effectively. See full prescribing information for LOTEMAX ® SM. LOTEMAX ® SM (loteprednol etabonate ophthalmic gel), for topical ophthalmic use Initial U.S. Approval: 1998 | Bausch & Lomb Incorporated |
| 24208-508 | These highlights do not include all the information needed to use LOTEPREDNOL ETABONATE OPHTHALMIC GEL safely and effectively. See full prescribing information for LOTEPREDNOL ETABONATE OPHTHALMIC GEL. LOTEPREDNOL ETABONATE OPHTHALMIC GEL 0.5%, for topical ophthalmic use. Initial U.S. Approval: 1998 | Bausch & Lomb Incorporated |
| 24208-508-01 | These highlights do not include all the information needed to use LOTEPREDNOL ETABONATE OPHTHALMIC GEL safely and effectively. See full prescribing information for LOTEPREDNOL ETABONATE OPHTHALMIC GEL. LOTEPREDNOL ETABONATE OPHTHALMIC GEL 0.5%, for topical ophthalmic use. Initial U.S. Approval: 1998 | Bausch & Lomb Incorporated |
| 46708-801 | These highlights do not include all the information needed to use LOTEPREDNOL ETABONATE and TOBRAMYCIN OPHTHALMIC SUSPENSION safely and effectively. See full prescribing information for LOTEPREDNOL ETABONATE and TOBRAMYCIN OPHTHALMIC SUSPENSION. LOTEPREDNOL ETABONATE and TOBRAMYCIN ophthalmic suspension 0.5%/0.3%, for topical ophthalmic use Initial U.S. Approval: 2004 | Alembic Pharmaceuticals Limited | Alembic Pharmaceuticals Limited (F3) |
| 46708-801-05 | These highlights do not include all the information needed to use LOTEPREDNOL ETABONATE and TOBRAMYCIN OPHTHALMIC SUSPENSION safely and effectively. See full prescribing information for LOTEPREDNOL ETABONATE and TOBRAMYCIN OPHTHALMIC SUSPENSION. LOTEPREDNOL ETABONATE and TOBRAMYCIN ophthalmic suspension 0.5%/0.3%, for topical ophthalmic use Initial U.S. Approval: 2004 | Alembic Pharmaceuticals Limited | Alembic Pharmaceuticals Limited (F3) |
| 46708-801-10 | These highlights do not include all the information needed to use LOTEPREDNOL ETABONATE and TOBRAMYCIN OPHTHALMIC SUSPENSION safely and effectively. See full prescribing information for LOTEPREDNOL ETABONATE and TOBRAMYCIN OPHTHALMIC SUSPENSION. LOTEPREDNOL ETABONATE and TOBRAMYCIN ophthalmic suspension 0.5%/0.3%, for topical ophthalmic use Initial U.S. Approval: 2004 | Alembic Pharmaceuticals Limited | Alembic Pharmaceuticals Limited (F3) |
| 50383-265 | Loteprednol Etabonate Ophthalmic Suspension, 0.5% | Akorn | Akorn Operating Company LLC |
| 50383-265-05 | Loteprednol Etabonate Ophthalmic Suspension, 0.5% | Akorn | Akorn Operating Company LLC |
| 50383-265-10 | Loteprednol Etabonate Ophthalmic Suspension, 0.5% | Akorn | Akorn Operating Company LLC |
| 50383-265-15 | Loteprednol Etabonate Ophthalmic Suspension, 0.5% | Akorn | Akorn Operating Company LLC |
| 54868-4277 | ALREX loteprednol etabonate ophthalmic suspension, 0.2% | Physicians Total Care, Inc. |
| 54868-4277-0 | ALREX loteprednol etabonate ophthalmic suspension, 0.2% | Physicians Total Care, Inc. |
| 54868-4277-1 | ALREX loteprednol etabonate ophthalmic suspension, 0.2% | Physicians Total Care, Inc. |
| 54868-4278 | LOTEMAX® loteprednol etabonate ophthalmic suspension, 0.5% | Physicians Total Care, Inc. |
| 54868-4278-0 | LOTEMAX® loteprednol etabonate ophthalmic suspension, 0.5% | Physicians Total Care, Inc. |
| 54868-4278-1 | LOTEMAX® loteprednol etabonate ophthalmic suspension, 0.5% | Physicians Total Care, Inc. |
| 60219-1362 | Loteprednol Etabonate Ophthalmic Suspension, 0.5% STERILE OPHTHALMIC SUSPENSION | Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals Private Limited |
| 60219-1362-1 | Loteprednol Etabonate Ophthalmic Suspension, 0.5% STERILE OPHTHALMIC SUSPENSION | Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals Private Limited |
| 60219-1362-2 | Loteprednol Etabonate Ophthalmic Suspension, 0.5% STERILE OPHTHALMIC SUSPENSION | Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals Private Limited |
| 60219-1362-3 | Loteprednol Etabonate Ophthalmic Suspension, 0.5% STERILE OPHTHALMIC SUSPENSION | Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals Private Limited |
| 60219-1366 | Loteprednol Etabonate Ophthalmic Suspension, 0.2% Sterile Rx only | Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals of New York, LLC | Amneal Pharmaceuticals Private Limited |
| 60219-1366-3 | Loteprednol Etabonate Ophthalmic Suspension, 0.2% Sterile Rx only | Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals of New York, LLC | Amneal Pharmaceuticals Private Limited |
| 60219-1367 | Loteprednol Etabonate Ophthalmic Suspension, 0.2% Sterile Rx only | Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals of New York, LLC | Amneal Pharmaceuticals Private Limited |
| 60219-1367-6 | Loteprednol Etabonate Ophthalmic Suspension, 0.2% Sterile Rx only | Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals of New York, LLC | Amneal Pharmaceuticals Private Limited |
| 62332-801 | These highlights do not include all the information needed to use LOTEPREDNOL ETABONATE and TOBRAMYCIN OPHTHALMIC SUSPENSION safely and effectively. See full prescribing information for LOTEPREDNOL ETABONATE and TOBRAMYCIN OPHTHALMIC SUSPENSION. LOTEPREDNOL ETABONATE and TOBRAMYCIN ophthalmic suspension 0.5%/0.3%, for topical ophthalmic use Initial U.S. Approval: 2004 | Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited (F3) |
| 62332-801-05 | These highlights do not include all the information needed to use LOTEPREDNOL ETABONATE and TOBRAMYCIN OPHTHALMIC SUSPENSION safely and effectively. See full prescribing information for LOTEPREDNOL ETABONATE and TOBRAMYCIN OPHTHALMIC SUSPENSION. LOTEPREDNOL ETABONATE and TOBRAMYCIN ophthalmic suspension 0.5%/0.3%, for topical ophthalmic use Initial U.S. Approval: 2004 | Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited (F3) |
| 62332-801-10 | These highlights do not include all the information needed to use LOTEPREDNOL ETABONATE and TOBRAMYCIN OPHTHALMIC SUSPENSION safely and effectively. See full prescribing information for LOTEPREDNOL ETABONATE and TOBRAMYCIN OPHTHALMIC SUSPENSION. LOTEPREDNOL ETABONATE and TOBRAMYCIN ophthalmic suspension 0.5%/0.3%, for topical ophthalmic use Initial U.S. Approval: 2004 | Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited (F3) |
| 62756-232 | Rx only Loteprednol Etabonate Ophthalmic Suspension 0.5% Sterile Ophthalmic Suspension | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited (formerly known as Sun Pharmaceutical Medicare Limited) |
| 62756-232-55 | Rx only Loteprednol Etabonate Ophthalmic Suspension 0.5% Sterile Ophthalmic Suspension | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited (formerly known as Sun Pharmaceutical Medicare Limited) |
| 62756-232-56 | Rx only Loteprednol Etabonate Ophthalmic Suspension 0.5% Sterile Ophthalmic Suspension | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited (formerly known as Sun Pharmaceutical Medicare Limited) |
| 62756-232-90 | Rx only Loteprednol Etabonate Ophthalmic Suspension 0.5% Sterile Ophthalmic Suspension | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited (formerly known as Sun Pharmaceutical Medicare Limited) |
| 68682-299 | Loteprednol Etabonate Ophthalmic Suspension 0.5% | Oceanside Pharmaceuticals | Bausch & Lomb Incorporated |
| 68682-299-05 | Loteprednol Etabonate Ophthalmic Suspension 0.5% | Oceanside Pharmaceuticals | Bausch & Lomb Incorporated |
| 68682-299-10 | Loteprednol Etabonate Ophthalmic Suspension 0.5% | Oceanside Pharmaceuticals | Bausch & Lomb Incorporated |
| 68682-299-15 | Loteprednol Etabonate Ophthalmic Suspension 0.5% | Oceanside Pharmaceuticals | Bausch & Lomb Incorporated |
| 70244-034 | Loteprednol Etabonate Ophthalmic Suspension, 0.5% | Sentiss Pharmaceuticals LLC | SENTISS AG | Ophtapharm AG |
| 70244-034-01 | Loteprednol Etabonate Ophthalmic Suspension, 0.5% | Sentiss Pharmaceuticals LLC | SENTISS AG | Ophtapharm AG |
| 70244-034-02 | Loteprednol Etabonate Ophthalmic Suspension, 0.5% | Sentiss Pharmaceuticals LLC | SENTISS AG | Ophtapharm AG |
| 70244-034-03 | Loteprednol Etabonate Ophthalmic Suspension, 0.5% | Sentiss Pharmaceuticals LLC | SENTISS AG | Ophtapharm AG |
| 70244-035 | Loteprednol Etabonate Ophthalmic Suspension, 0.2% | Sentiss Pharmaceuticals LLC | SENTISS AG | Ophtapharm AG |
| 70244-035-01 | Loteprednol Etabonate Ophthalmic Suspension, 0.2% | Sentiss Pharmaceuticals LLC | SENTISS AG | Ophtapharm AG |
| 70244-035-02 | Loteprednol Etabonate Ophthalmic Suspension, 0.2% | Sentiss Pharmaceuticals LLC | SENTISS AG | Ophtapharm AG |
| 70244-036 | These highlights do not include all the information needed to use LOTEPREDNOL ETABONATE OPHTHALMIC GEL safely and effectively. See full prescribing information for LOTEPREDNOL ETABONATE OPHTHALMIC GEL. LOTEPREDNOL ETABONATE ophthalmic gel, for topical ophthalmic use Initial U.S. Approval: 1998 | Sentiss Pharmaceuticals LLC | SENTISS AG | Ophtapharm AG |
| 70244-036-01 | These highlights do not include all the information needed to use LOTEPREDNOL ETABONATE OPHTHALMIC GEL safely and effectively. See full prescribing information for LOTEPREDNOL ETABONATE OPHTHALMIC GEL. LOTEPREDNOL ETABONATE ophthalmic gel, for topical ophthalmic use Initial U.S. Approval: 1998 | Sentiss Pharmaceuticals LLC | SENTISS AG | Ophtapharm AG |
| 70748-300 | Loteprednol Etabonate Ophthalmic Suspension 0.5% STERILE OPHTHALMIC SUSPENSION Rx Only | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED |
| 70748-300-01 | Loteprednol Etabonate Ophthalmic Suspension 0.5% STERILE OPHTHALMIC SUSPENSION Rx Only | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED |
| 70748-300-02 | Loteprednol Etabonate Ophthalmic Suspension 0.5% STERILE OPHTHALMIC SUSPENSION Rx Only | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED |
| 70748-300-03 | Loteprednol Etabonate Ophthalmic Suspension 0.5% STERILE OPHTHALMIC SUSPENSION Rx Only | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED |
| 71571-121 | These highlights do not include all the information needed to use INVELTYS ® safely and effectively. See full prescribing information for INVELTYS. INVELTYS (loteprednol etabonate ophthalmic suspension) 1%, for topical ophthalmic use Initial U.S. Approval: 1998 | ALCON LABORATORIES, INC. |
| 71571-121-20 | These highlights do not include all the information needed to use INVELTYS ® safely and effectively. See full prescribing information for INVELTYS. INVELTYS (loteprednol etabonate ophthalmic suspension) 1%, for topical ophthalmic use Initial U.S. Approval: 1998 | ALCON LABORATORIES, INC. |
| 71571-121-28 | These highlights do not include all the information needed to use INVELTYS ® safely and effectively. See full prescribing information for INVELTYS. INVELTYS (loteprednol etabonate ophthalmic suspension) 1%, for topical ophthalmic use Initial U.S. Approval: 1998 | ALCON LABORATORIES, INC. |
| 71571-333 | These highlights do not include all the information needed to use EYSUVIS™ safely and effectively. See full prescribing information for EYSUVIS. EYSUVIS (loteprednol etabonate ophthalmic suspension) 0.25%, for topical ophthalmic use Initial U.S. Approval: 1998 | ALCON LABORATORIES, INC. |
| 71571-333-01 | These highlights do not include all the information needed to use EYSUVIS™ safely and effectively. See full prescribing information for EYSUVIS. EYSUVIS (loteprednol etabonate ophthalmic suspension) 0.25%, for topical ophthalmic use Initial U.S. Approval: 1998 | ALCON LABORATORIES, INC. |
| 71571-333-24 | These highlights do not include all the information needed to use EYSUVIS™ safely and effectively. See full prescribing information for EYSUVIS. EYSUVIS (loteprednol etabonate ophthalmic suspension) 0.25%, for topical ophthalmic use Initial U.S. Approval: 1998 | ALCON LABORATORIES, INC. |
| 71571-333-83 | These highlights do not include all the information needed to use EYSUVIS™ safely and effectively. See full prescribing information for EYSUVIS. EYSUVIS (loteprednol etabonate ophthalmic suspension) 0.25%, for topical ophthalmic use Initial U.S. Approval: 1998 | ALCON LABORATORIES, INC. |
| 72485-630 | These highlights do not include all the information needed to use LOTEPREDNOL ETABONATE OPHTHALMIC GEL safely and effectively. See full prescribing information for LOTEPREDNOL ETABONATE OPHTHALMIC GEL. LOTEPREDNOL ETABONATE ophthalmic gel, for topical ophthalmic use Initial U.S. Approval: 1998 | ARMAS PHARMACEUTICALS INC. | SENTISS AG | Ophtapharm AG |
| 72485-630-05 | These highlights do not include all the information needed to use LOTEPREDNOL ETABONATE OPHTHALMIC GEL safely and effectively. See full prescribing information for LOTEPREDNOL ETABONATE OPHTHALMIC GEL. LOTEPREDNOL ETABONATE ophthalmic gel, for topical ophthalmic use Initial U.S. Approval: 1998 | ARMAS PHARMACEUTICALS INC. | SENTISS AG | Ophtapharm AG |
| 72485-653 | Loteprednol Etabonate Ophthalmic Suspension, 0.2% | ARMAS PHARMACEUTICALS INC. | SENTISS AG | Ophtapharm AG |
| 72485-653 | Loteprednol Etabonate Ophthalmic Suspension, 0.2% | Sportpharm LLC |
| 72485-653-05 | Loteprednol Etabonate Ophthalmic Suspension, 0.2% | ARMAS PHARMACEUTICALS INC. | SENTISS AG | Ophtapharm AG |
| 72485-653-10 | Loteprednol Etabonate Ophthalmic Suspension, 0.2% | ARMAS PHARMACEUTICALS INC. | SENTISS AG | Ophtapharm AG |
| 72485-665 | Loteprednol Etabonate Ophthalmic Suspension, 0.5% | ARMAS PHARMACEUTICALS INC. | SENTISS AG | Ophtapharm AG |
| 72485-665-05 | Loteprednol Etabonate Ophthalmic Suspension, 0.5% | ARMAS PHARMACEUTICALS INC. | SENTISS AG | Ophtapharm AG |
| 72485-665-10 | Loteprednol Etabonate Ophthalmic Suspension, 0.5% | ARMAS PHARMACEUTICALS INC. | SENTISS AG | Ophtapharm AG |
| 72485-665-15 | Loteprednol Etabonate Ophthalmic Suspension, 0.5% | ARMAS PHARMACEUTICALS INC. | SENTISS AG | Ophtapharm AG |
| 72603-324 | Rx only Loteprednol Etabonate Ophthalmic Suspension 0.5% Sterile Ophthalmic Suspension | NorthStar RxLLC | Sun Pharmaceutical Industries Limited (formerly known as Sun Pharmaceutical Medicare Limited) |
| 72603-324-01 | Rx only Loteprednol Etabonate Ophthalmic Suspension 0.5% Sterile Ophthalmic Suspension | NorthStar RxLLC | Sun Pharmaceutical Industries Limited (formerly known as Sun Pharmaceutical Medicare Limited) |
| 72603-324-02 | Rx only Loteprednol Etabonate Ophthalmic Suspension 0.5% Sterile Ophthalmic Suspension | NorthStar RxLLC | Sun Pharmaceutical Industries Limited (formerly known as Sun Pharmaceutical Medicare Limited) |
| 72603-324-03 | Rx only Loteprednol Etabonate Ophthalmic Suspension 0.5% Sterile Ophthalmic Suspension | NorthStar RxLLC | Sun Pharmaceutical Industries Limited (formerly known as Sun Pharmaceutical Medicare Limited) |
| 82260-299 | Loteprednol Etabonate Ophthalmic Suspension 0.5% STERILE OPHTHALMIC SUSPENSION Rx only | Bausch & Lomb Americas Inc. | Bausch & Lomb Incorporated |
| 82260-299-05 | Loteprednol Etabonate Ophthalmic Suspension 0.5% STERILE OPHTHALMIC SUSPENSION Rx only | Bausch & Lomb Americas Inc. | Bausch & Lomb Incorporated |
| 82260-299-10 | Loteprednol Etabonate Ophthalmic Suspension 0.5% STERILE OPHTHALMIC SUSPENSION Rx only | Bausch & Lomb Americas Inc. | Bausch & Lomb Incorporated |
| 82260-299-15 | Loteprednol Etabonate Ophthalmic Suspension 0.5% STERILE OPHTHALMIC SUSPENSION Rx only | Bausch & Lomb Americas Inc. | Bausch & Lomb Incorporated |
| 82260-358 | These highlights do not include all the information needed to use LOTEPREDNOL ETABONATE AND TOBRAMYCIN OPHTHALMIC SUSPENSION safely and effectively. See full prescribing information for LOTEPREDNOL ETABONATE AND TOBRAMYCIN OPHTHALMIC SUSPENSION. LOTEPREDNOL ETABONATE AND TOBRAMYCIN ophthalmic suspension 0.5%/0.3%, for topical ophthalmic use Initial U.S. Approval: 2004 | Bausch & Lomb Americas Inc. | Bausch & Lomb Incorporated |
| 82260-358-05 | These highlights do not include all the information needed to use LOTEPREDNOL ETABONATE AND TOBRAMYCIN OPHTHALMIC SUSPENSION safely and effectively. See full prescribing information for LOTEPREDNOL ETABONATE AND TOBRAMYCIN OPHTHALMIC SUSPENSION. LOTEPREDNOL ETABONATE AND TOBRAMYCIN ophthalmic suspension 0.5%/0.3%, for topical ophthalmic use Initial U.S. Approval: 2004 | Bausch & Lomb Americas Inc. | Bausch & Lomb Incorporated |
| 82260-358-10 | These highlights do not include all the information needed to use LOTEPREDNOL ETABONATE AND TOBRAMYCIN OPHTHALMIC SUSPENSION safely and effectively. See full prescribing information for LOTEPREDNOL ETABONATE AND TOBRAMYCIN OPHTHALMIC SUSPENSION. LOTEPREDNOL ETABONATE AND TOBRAMYCIN ophthalmic suspension 0.5%/0.3%, for topical ophthalmic use Initial U.S. Approval: 2004 | Bausch & Lomb Americas Inc. | Bausch & Lomb Incorporated |
| 82260-361 | Loteprednol Etabonate Ophthalmic Suspension, 0.2% STERILE OPHTHALMIC SUSPENSION | Bausch & Lomb Americas Inc. | Bausch & Lomb Incorporated |
| 82260-361-05 | Loteprednol Etabonate Ophthalmic Suspension, 0.2% STERILE OPHTHALMIC SUSPENSION | Bausch & Lomb Americas Inc. | Bausch & Lomb Incorporated |
| 82260-508 | These highlights do not include all the information needed to use LOTEPREDNOL ETABONATE OPHTHALMIC GEL safely and effectively. See full prescribing information for LOTEPREDNOL ETABONATE OPHTHALMIC GEL. LOTEPREDNOL ETABONATE OPHTHALMIC GEL, for topical ophthalmic use Initial U.S. Approval: 1998 | Bausch & Lomb Americas Inc. | Bausch & Lomb Incorporated |
| 82260-508-01 | These highlights do not include all the information needed to use LOTEPREDNOL ETABONATE OPHTHALMIC GEL safely and effectively. See full prescribing information for LOTEPREDNOL ETABONATE OPHTHALMIC GEL. LOTEPREDNOL ETABONATE OPHTHALMIC GEL, for topical ophthalmic use Initial U.S. Approval: 1998 | Bausch & Lomb Americas Inc. | Bausch & Lomb Incorporated |
| 85766-193 | Loteprednol Etabonate Ophthalmic Suspension, 0.2% | Sportpharm LLC |
| 85766-193-05 | Loteprednol Etabonate Ophthalmic Suspension, 0.2% | Sportpharm LLC |